DE60100431D1 - Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln - Google Patents

Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln

Info

Publication number
DE60100431D1
DE60100431D1 DE60100431T DE60100431T DE60100431D1 DE 60100431 D1 DE60100431 D1 DE 60100431D1 DE 60100431 T DE60100431 T DE 60100431T DE 60100431 T DE60100431 T DE 60100431T DE 60100431 D1 DE60100431 D1 DE 60100431D1
Authority
DE
Germany
Prior art keywords
combination
mirtazapine
paracetamol
flamming
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60100431T
Other languages
English (en)
Other versions
DE60100431T2 (de
Inventor
Victor Johannes Nickolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60100431D1 publication Critical patent/DE60100431D1/de
Publication of DE60100431T2 publication Critical patent/DE60100431T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE60100431T 2000-04-05 2001-04-04 Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln Expired - Fee Related DE60100431T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00201239 2000-04-05
EP00201239 2000-04-05
PCT/EP2001/004069 WO2001074340A2 (en) 2000-04-05 2001-04-04 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

Publications (2)

Publication Number Publication Date
DE60100431D1 true DE60100431D1 (de) 2003-08-07
DE60100431T2 DE60100431T2 (de) 2004-05-19

Family

ID=8171309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60100431T Expired - Fee Related DE60100431T2 (de) 2000-04-05 2001-04-04 Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln

Country Status (24)

Country Link
EP (1) EP1242092B1 (de)
JP (1) JP2004500410A (de)
KR (1) KR20020086945A (de)
CN (1) CN1537006A (de)
AT (1) ATE244010T1 (de)
AU (2) AU7393201A (de)
BR (1) BR0109881A (de)
CA (1) CA2404358A1 (de)
CZ (1) CZ295982B6 (de)
DE (1) DE60100431T2 (de)
DK (1) DK1242092T3 (de)
ES (1) ES2201039T3 (de)
HK (1) HK1047547B (de)
HU (1) HUP0300717A3 (de)
IL (1) IL151815A0 (de)
MX (1) MXPA02009811A (de)
NO (1) NO20024684L (de)
NZ (1) NZ521631A (de)
PL (1) PL366237A1 (de)
PT (1) PT1242092E (de)
RU (1) RU2002129356A (de)
SK (1) SK14162002A3 (de)
WO (1) WO2001074340A2 (de)
ZA (1) ZA200207701B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
EP1792618A1 (de) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine zur Behandlung von Schmerz
WO2020229388A1 (en) 2019-05-12 2020-11-19 Curatis Ag Mirtazapine for use in medication overuse headache based on tension-type headache
KR102549596B1 (ko) 2021-12-14 2023-07-03 재단법인 환동해산업연구원 생리활성을 가지는 사카이대마디말 추출물 및 그 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache

Also Published As

Publication number Publication date
JP2004500410A (ja) 2004-01-08
AU2001273932B2 (en) 2005-07-14
WO2001074340A2 (en) 2001-10-11
HUP0300717A3 (en) 2004-11-29
PL366237A1 (en) 2005-01-24
MXPA02009811A (es) 2003-05-27
SK14162002A3 (sk) 2003-03-04
WO2001074340A3 (en) 2002-07-18
RU2002129356A (ru) 2004-03-27
AU7393201A (en) 2001-10-15
CZ20023322A3 (cs) 2003-01-15
EP1242092A2 (de) 2002-09-25
DK1242092T3 (da) 2003-10-06
DE60100431T2 (de) 2004-05-19
PT1242092E (pt) 2003-11-28
HK1047547A1 (en) 2003-02-28
CN1537006A (zh) 2004-10-13
NO20024684L (no) 2002-11-21
ATE244010T1 (de) 2003-07-15
ES2201039T3 (es) 2004-03-16
NZ521631A (en) 2005-01-28
KR20020086945A (ko) 2002-11-20
EP1242092B1 (de) 2003-07-02
CA2404358A1 (en) 2001-10-11
ZA200207701B (en) 2004-02-10
HUP0300717A2 (hu) 2003-07-28
CZ295982B6 (cs) 2005-12-14
HK1047547B (zh) 2003-10-10
IL151815A0 (en) 2003-04-10
NO20024684D0 (no) 2002-09-30
BR0109881A (pt) 2003-06-03

Similar Documents

Publication Publication Date Title
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
DE69805202D1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
DE50207442D1 (de) Behandlung der akne mit lipoxygenase inhibitoren
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE602004022285D1 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE60317098D1 (de) Carbostyril-derivate mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von gemütskrankheiten
DE60100431D1 (de) Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE407925T1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
EA200501514A1 (ru) Сочетания действующих веществ и способы лечения злоупотребления алкоголем
DE50302552D1 (de) Verwendung von treosulfan und derivaten davon zur behandlung der multiplen sklerose
NO20030483D0 (no) Assosiasjoner av dalfopristin/quinupristin med cefpirom
HUP0402645A2 (hu) Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee